SunTrust Starts Catalyst Pharmaceutical Partners (CPRX) at Buy
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $31.45 +0.03%
Rating Summary:
7 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 2
Rating Summary:
7 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 2
Join SI Premium – FREE
SunTrust Robinson Humphrey initiated coverage on Catalyst Pharmaceutical Partners (NASDAQ: CPRX) with a Buy rating and a price target of $7.00.
For an analyst ratings summary and ratings history on Catalyst Pharmaceutical Partners click here. For more ratings news on Catalyst Pharmaceutical Partners click here.
Shares of Catalyst Pharmaceutical Partners closed at $3.73 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vamorolone Demonstrates On-Target Glucocorticoid Activity Without the Immunosuppression Characteristic of Traditional Corticosteroids at Clinical Doses
- Maxim Group Starts Amass brands (AMSS) at Buy
- Catalyst Pharma reports vamorolone Phase 1 data on immune activity
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
SunTrust Robinson HumphreySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
